Search research articles
Contact Us
Filters
Showing results (1-10 of 66) with videos related to
Page
of 7
Sort By:
Nature Reviews. Cancer
|
October 7, 2024
Challenging the status quo to improve the translational potential of preclinical oncology studies
Kate Connor, Anna Golebiewska, Annette T Byrne
Gastroenterology
|
January 24, 2020
Precision Therapy in RAS Mutant Colorectal Cancer
Rodrigo Dienstmann, Kate Connor, Annette T Byrne, et al.
Photochemistry and Photobiology
|
August 18, 2009
Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy
Aisling E O'Connor, William M Gallagher, Annette T Byrne
BMC Medical Education
|
December 11, 2014
Comparison of performance in a four year graduate entry medical programme and a traditional five/six year programme
Annette T Byrne, Richard Arnett, Tom Farrell, et al.
Gastroenterology
|
October 18, 2019
Therapeutic Targeting of the Colorectal Tumor Stroma
Wolf H Fridman, Ian Miller, Catherine Sautès-Fridman, et al.
Microarrays (Basel, Switzerland)
|
September 8, 2016
Integrating Colon Cancer Microarray Data: Associating Locus-Specific Methylation Groups to Gene Expression-Based Classifications
Ana Barat, Heather J Ruskin, Annette T Byrne, et al.
Public Health Nutrition
|
April 17, 2014
Comparison of anthropometric-based equations for estimation of body fat percentage in a normal-weight and overweight female cohort: validation via air-displacement plethysmography
Derry Temple, Romain Denis, Marianne C Walsh, et al.
Expert Opinion on Therapeutic Targets
|
June 30, 2016
The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Markus Joerger, Stephen P Finn, Sinead Cuffe, et al.
The Journal of Pathology
|
December 8, 2009
Bioluminescent imaging: a critical tool in pre-clinical oncology research
Karen O'Neill, Scott K Lyons, William M Gallagher, et al.
Investigational New Drugs
|
March 16, 2010
Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells
Norma O'Donovan, Annette T Byrne, Aisling E O'Connor, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 66) with videos related to
Sort By:
Page
of 7
Nature Reviews. Cancer
|
October 7, 2024
Challenging the status quo to improve the translational potential of preclinical oncology studies
Kate Connor, Anna Golebiewska, Annette T Byrne
Gastroenterology
|
January 24, 2020
Precision Therapy in RAS Mutant Colorectal Cancer
Rodrigo Dienstmann, Kate Connor, Annette T Byrne, et al.
Photochemistry and Photobiology
|
August 18, 2009
Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy
Aisling E O'Connor, William M Gallagher, Annette T Byrne
BMC Medical Education
|
December 11, 2014
Comparison of performance in a four year graduate entry medical programme and a traditional five/six year programme
Annette T Byrne, Richard Arnett, Tom Farrell, et al.
Gastroenterology
|
October 18, 2019
Therapeutic Targeting of the Colorectal Tumor Stroma
Wolf H Fridman, Ian Miller, Catherine Sautès-Fridman, et al.
Microarrays (Basel, Switzerland)
|
September 8, 2016
Integrating Colon Cancer Microarray Data: Associating Locus-Specific Methylation Groups to Gene Expression-Based Classifications
Ana Barat, Heather J Ruskin, Annette T Byrne, et al.
Public Health Nutrition
|
April 17, 2014
Comparison of anthropometric-based equations for estimation of body fat percentage in a normal-weight and overweight female cohort: validation via air-displacement plethysmography
Derry Temple, Romain Denis, Marianne C Walsh, et al.
Expert Opinion on Therapeutic Targets
|
June 30, 2016
The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?
Markus Joerger, Stephen P Finn, Sinead Cuffe, et al.
The Journal of Pathology
|
December 8, 2009
Bioluminescent imaging: a critical tool in pre-clinical oncology research
Karen O'Neill, Scott K Lyons, William M Gallagher, et al.
Investigational New Drugs
|
March 16, 2010
Synergistic interaction between trastuzumab and EGFR/HER-2 tyrosine kinase inhibitors in HER-2 positive breast cancer cells
Norma O'Donovan, Annette T Byrne, Aisling E O'Connor, et al.
Page
of 7